Cerebrospinal fluid Aβ40 improves the interpretation of Aβ42 concentration for diagnosing Alzheimer’s disease.

Cerebrospinal fluid Aβ40 improves the interpretation of Aβ42 concentration for diagnosing Alzheimer’s disease.

The combination of decreased amyloid β42 (Aβ42) and increased total tau proteins (T-Tau) and phosphorylated tau (P-Tau) in cerebrospinal fluid (CSF) has recently been considered as a biological diagnostic criterion of Alzheimer’s disease (AD). Previous studies showed significant heterogeneity in CSF...

Full description

Bibliographic Details
Main Authors: Aline eDorey, Armand ePerret-Liaudet, Yannick eTholance, Anthony eFourier, Isabelle eQuadrio
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-11-01
Series:Frontiers in Neurology
Subjects:
Cerebrospinal Fluid
Dementia
Alzheimer
Aβ42
Aβ40
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00247/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00247/full

Similar Items